Clinical leadership Centinel Spine boasts a globally proven prodisc total disc replacement platform with over 540 published papers and 225,000 implantations, signaling a strong case for expanding adoption in neurosurgery and orthopedic centers seeking evidence-based spine solutions.

Cervical and lumbar The company offers both cervical and lumbar motion-preserving technologies, making it a comprehensive partner for clinics performing anterior column reconstruction and enabling cross-sell opportunities across multiple spine segments.

Recent launches Frequent product introductions including cervical TDR technologies and the FORTOS-C plating system indicate an active product roadmap and potential for renewals, upgrades, and bundled advocating for hospital procurement cycles.

Private equity ready With revenue in the mid-range and a substantial funding level, Centinel Spine represents a scalable growth profile for potential acquisitions, distribution partnerships, or strategic collaborations with larger medical device players seeking spine portfolio expansion.

Global adoption Extensive clinical validation and international implantations position Centinel Spine as a credible partner for international distributors, academic medical centers, and regulated markets pursuing standards-based, evidence-backed spine solutions.